[ Price : $8.95]
FDA warns six companies that they are marketing unapproved fat-dissolving drugs.[ Price : $8.95]
FDA accepts a Sydnexis NDA for SYD-101 (topical low-dose atropine) for treating progression of pediatric myopia.dr[ Price : $8.95]
FDA clears a Beckman Coulter Diagnostics 510(k) for its DxC 500i Clinical Analyzer.[ Price : $8.95]
CDRH chief scientist and deputy Center director Doug Kelly abruptly resigns after less than five years at the agency.[ Price : $8.95]
FDA belatedly inspects Indias Glenmark Pharmaceuticals after a recent ProPublica investigative report found that the agency hadnt ...[ Price : $8.95]
FDA names former business consultant Jim Traficant as chief of staff where he will oversee and lead the agencys major initiatives....[ Price : $8.95]
Mineralys Therapeutics reports positive topline data from its pivotal Launch-HTN Phase 3 and pivotal Advance-HTN Phase 2 trials as...[ Price : $8.95]
FDA clarifies its policies for compounders of GLP-1 products for weight-loss and treating diabetes following a court ruling in Tex...